Arbutus Biopharma Corp (ABUS)
$4.21 -1.64% Close Oct 30, 2026 Live
Arbutus Biopharma stock today
Arbutus Biopharma closed at $4.21 on October 30, 2026, down 1.64% on the day. Over the past year it returned -13.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $832 million.
$4.00$4.50$5.00
NovJan 2026MarMayJulSep
| Period | ABUS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -11.9% | -0.9% |
| 3 months | -4.5% | +2.1% |
| Year to date | -12.5% | +11.7% |
| 1 year | -13.0% | +12.4% |
| 3 years | +136.5% | +88.5% |
| 5 years | +4.5% | +76.0% |
Key statistics
- Market value
- $832M
- P/E (trailing)
- 5.3
- Forward P/E
- 9.2
- Price / sales
- 4.6
- 52-week range
- $3.67 to $5.22
- Next report
- Nov 16, 2026 (estimated)
About Arbutus Biopharma
Biopharmaceutical company developing antiviral medicines.
Sector: Health Care
More on Arbutus Biopharma
- Financials: revenue, earnings and segmentsRevenue +128% in the year to Dec 2025
- Valuation: P/E history and peersP/E 5.3
- Returns: what $1,000 became$1,000 ten years ago is $1,337 today
No forecast, no recommendation. This page describes Arbutus Biopharma Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.